• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

hDHODH-IN-1

CAS No. 1173715-42-8

hDHODH-IN-1 ( —— )

产品货号. M26247 CAS No. 1173715-42-8

hDHODH-IN-1 是一种人二氢乳清酸脱氢酶 (hDHODH) 抑制剂,具有抗炎作用。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥1936 有现货
10MG ¥3102 有现货
25MG ¥5241 有现货
50MG ¥7468 有现货
100MG ¥10125 有现货
500MG ¥20169 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    hDHODH-IN-1
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    hDHODH-IN-1 是一种人二氢乳清酸脱氢酶 (hDHODH) 抑制剂,具有抗炎作用。
  • 产品描述
    hDHODH-IN-1 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an anti-inflammatory effect.(In Vitro):Dihydroorotate dehydrogenase (DHODH) is a class-2 dihydroorotate dehydrogenase in human.?Inhibitors have been developed to eliminate human DHODH (hDHODH) activity, which is associated with cancers,inflammatory diseases , and autoimmune and multiple sclerosis because DHODH is required to ensure proliferating-cell viability.
  • 体外实验
    Human dihydroorotate dehydrogenase (hDHODH) is a class-2 dihydroorotate dehydrogenase. Because DHODH is required to ensure proliferating-cell viability, inhibitors have been developed to eliminate human DHODH (hDHODH) activity, which is associated with cancers, multiple sclerosis, and autoimmune and inflammatory diseases.
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    Dehydrogenase
  • 受体
    PEGs
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1173715-42-8
  • 分子量
    278.311
  • 分子式
    C17H14N2O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO : 250 mg/mL (898.28 mM)
  • SMILES
    C\C(O)=C(/C#N)C(=O)Nc1ccc(cc1)-c1ccccc1
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
产品手册
关联产品
  • DHODH-IN-16

    DHODH-IN-16 是二氢乳清酸脱氢酶的有效抑制剂(DHODH,对于人类,IC50 = 0.396 nM)。

  • DSM421

    DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax.

  • ML-148

    ML-148 是 15-羟基前列腺素脱氢酶 (15-PGDH,IC50 = 56 nM) 的选择性抑制剂。